Device type · PCL
Enzyme Linked Immunoabsorbent Assay, Rubeola Igm
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PCL
Microbiology
Device class
Class I
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Enzyme Linked Immunoabsorbent Assay, Rubeola Igm
- Product code
- PCL
- Device class
- Class I
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3520
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for PCL
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2552-2025 · Started Jul 17, 2025 · Posted by FDA Sep 11, 2025
Reason given: Measles IgM Test Kit lacks premarket approval or clearance.
Cause as FDA categorized it: No Marketing Application
Z-1503-2021 · Started Mar 17, 2021
Reason given: Positive Control may run high out of its assigned ISR range and result in an invalid run and necessitate retesting
Cause as FDA categorized it: Under Investigation by firm
- Trinity Biotech Captia Measles IgM, REF/Product Code 2326060,Test Kit for 96 Determinations, IVDTerminated
Clark Laboratories, Inc. (dba,Trinity Biotech USA)
Z-2782-2016 · Started Jul 11, 2016 · Posted by FDA Sep 12, 2016
Reason given: The product lot failed to meet QC acceptance criteria during stability testing. The Calibrator OD was dropping causing the positive control to be invalid (running high out of range).
Cause as FDA categorized it: Nonconforming Material/Component
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.